NetworkNewsBreaks

FridayMar 18, 2022 11:25 am

NetworkNewsBreaks – Red White & Bloom Brands Inc.’s (CSE: RWB) (OTCQX: RWBYF) Acquisition Strategy Spearheading Expansion, Premium Inventory Production

Red White & Bloom Brands (CSE: RWB) (OTCQX: RWBYF), a premium cannabis brand multistate operator, has been building assets steadily in Michigan, Florida, Illinois, Massachusetts, and Arizona, while working to establish the quality and consistency that wellness consumers seek. The company announced full licensing for manufacturing both medical and adult-use cannabis products in Michigan in January, along with the closing of a lease assignment for a 15,000-square-foot manufacturing, processing and distribution facility in the city of Warren. A recent article reads: “The manufacturing facility is a key part of RWB’s acquisition strategy for 18 Michigan dispensaries, four cultivation facilities and…

Continue Reading

FridayMar 18, 2022 10:24 am

NetworkNewsBreaks – Cerberus Cyber Sentinel Corp. (NASDAQ: CISO) CEO Warns of Cyber Attacks, Notes Importance of Cybersecurity

Cerberus Cyber Sentinel (NASDAQ: CISO) CEO David Jemmett stated in a recent blog that the Russian aggression in Ukraine is creating both humanitarian crises as well as fomenting cybersecurity insurrection that few organizations are prepared to weather. CISO is a global managed compliance and cybersecurity provider (“MCCP”) based in Scottsdale, Arizona. Recent recommendations from the U.S. Cybersecurity and Infrastructure Security Agency (“CISA) encourage organizations to adopt a heightened posture when it comes to cybersecurity and protecting their most critical assets. Jemmett observed that reevaluating how organizations look at such land-based conflicts and understand the reasons why this is a critical…

Continue Reading

ThursdayMar 17, 2022 3:07 pm

NetworkNewsBreaks – Mydecine Innovations Group Inc. (NEO: MYCO) (OTC: MYCOF) Playing Pivotal Role in Renaissance of Psychedelics

Mydecine Innovations (NEO: MYCO) (OTC: MYCOF), a biotechnology and digital technology company aiming to transform the treatment of mental health and addiction disorders, is among organizations, working alongside researchers at the center of the veritable renaissance of psychedelics. “Mydecine is playing a crucial role in advancing the knowledge of the benefits of psychedelics by developing innovative first- and second-generation novel compounds for the treatment of mental health and addiction and sequentially collaborating with academics to undertake vital clinical research on them. So far, Mydecine has partnered with Johns Hopkins University to launch a clinical trial utilizing psilocybin for smoking cessation. Led…

Continue Reading

ThursdayMar 17, 2022 2:55 pm

NetworkNewsBreaks – Tokocrypto Introduces AZNVerse, a Unique NFT Collection Representing Diverse Asian Cultures Around the World

Tokocrypto today announced the upcoming launch of its first NFT collection — AZNVerse — with the public sale slated for March 19, 2022. The 10,000 unique NFT characters, which represent diverse Asian cultures around the world, live on the BSC network and are available in numerous designs, including notable and historical Asian figures. Holders of AZN NFTs gain access to the exclusive CRAClub community and T-Hub — Asia’s first crypto community hub, initiated by Tokocrypto. AZN holders will also reap growing benefits and offerings aimed at helping them gain financial freedom. “Tokocrypto has grown beyond being just Indonesia’s biggest crypto…

Continue Reading

ThursdayMar 17, 2022 2:46 pm

NetworkNewsBreaks – CNS Pharmaceuticals Inc. (NASDAQ: CNSP) CEO Discusses Significant Milestone in Advancing Berubicin

CNS Pharmaceuticals (NASDAQ: CNSP), a biopharmaceutical company specializing in the development of novel treatments for primary and metastatic cancers in the brain and central nervous system, recently participated in the Virtual Investor 2022 Top Picks Conference. The company’s CEO John Climaco provided a corporate presentation and participated in a moderated questions and answer session during the event. Berubicin, a novel anthracycline and the first in its drug class to appear to cross the blood-brain barrier, is CNS Pharmaceuticals’ lead drug candidate. “The company is currently developing treatments using Berubicin for serious brain and central nervous system oncology indications, including glioblastoma…

Continue Reading

ThursdayMar 17, 2022 2:09 pm

NetworkNewsBreaks – Knightscope Inc. (NASDAQ: KSCP) to Host Virtual Town Hall

Knightscope (NASDAQ: KSCP), a developer of advanced physical security technologies focused on enhancing U.S. security operations, announced that it will be holding a virtual Town Hall at 11 a.m. PT / 2 p.m. ET on Thursday, March 31, 2022. The announcement reads, “Knightscope’s CEO, William Santana Li, will be taking 90 minutes of your questions in an ‘Ask Me Anything’ format. As long as he can legally answer it, he likely will! Click here to RSVP. The session will be livestreamed and recorded.” To view the full press release, visit https://nnw.fm/TRRj3 About Knightscope Knightscope is an advanced security technology company…

Continue Reading

ThursdayMar 17, 2022 1:54 pm

NetworkNewsBreaks – DigitalSelf Announces Next-Gen Web3 Solutions at Premier Soccer Event

DigitalSelf has launched its proprietary self-service web3 technology. Chris Pulley, CEO of CCP Digital and interim CEO of DigitalSelf, demonstrated the cutting-edge virtual platform at Soccerex, soccer’s leading global business event. The gathering of sports industry professionals provided an ideal place for the presentation, which showed how DigitalSelf brings people together through live experiences and provides cutting-edge web3 solutions for brands and content providers. The innovative tech, which features installation of 360-degree cameras that livestream the action, creates a way for fans around the world to experience live events from their homes. Through DigitalSelf, those attending events virtually can access…

Continue Reading

ThursdayMar 17, 2022 1:30 pm

NetworkNewsBreaks – Pressure BioSciences Inc. (PBIO) Issues Update on Key 2022 Goals and Milestones, Planned Uplist to National Exchange

Pressure BioSciences (OTCQB: PBIO) (“PBI”), a leader in the development and sale of broadly enabling, pressure-based instruments, consumables and specialty services to the worldwide biotechnology, biotherapeutics, nutraceuticals, cosmetics, agriculture, and food and beverage industries, today updated stakeholders on the company's key 2022 goals. PBI believes these goals are attainable in the current fiscal year and that their achievement will put the company on a rapid path to sustained growth, value increase and profitability. “In addition to the record number of instrument orders for a month, interest and engagement with our enabling BaroFold Platform protein refolding services has grown significantly over…

Continue Reading

ThursdayMar 17, 2022 1:06 pm

NetworkNewsBreaks – SPYR Inc. (SPYR) Subsidiary Names Seasoned Brand Veteran to Advisory Board

SPYR (OTCQB: SPYR), dba SPYR Technologies, a technology company and its subsidiary, Applied Magix Inc., have announced a new member of the Applied Magix advisory Board. Michael Teitelbaum, a senior brand integrity manager at Jazwares, will be bringing his expertise to the board. In the announcement, Teitelbaum noted that he welcomes the opportunity to share his expertise and experience and guide Applied Magix to new heights. Applied Magix develops and resells Apple(R) ecosystem compatible products in the growing multibillion-dollar IoT smart-home and connected-car markets. “I’m genuinely excited to have Mike on our advisory board, offering us his expertise and experience,” said…

Continue Reading

ThursdayMar 17, 2022 11:54 am

NetworkNewsBreaks – Delic Holdings Inc. (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0) CEO, Cofounder Featured on the Jesse Tee Show Interview

Delic Holdings (CSE: DELC) (OTCQB: DELCF) (FRA: 6X0), a leader in new medicines and treatments for a modern world, and company CEO and cofounder Matt Stang were spotlighted during a recent segment of the Jesse Tee Show. During the interview, Stang provided a summary of the journey to his present position with Delic Holdings, noting that he started as an intern with “High Times.” He worked in several positions at the publication, eventually buying out one of the owners. Stang also discussed the therapeutic potential of psychedelic compounds and provided a brief history of Delic. “In 2016, we put ‘High Times’ up…

Continue Reading